WTA
TXG icon

Washington Trust Advisors’s 10x Genomics TXG Stock Holding History

Washington Trust Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-83
Closed -$3.02K – 795
2022
Q4 		$3.02K Sell
83
-230
-73% -$7.52K ﹤0.01% 681
2022
Q3 		$9K Sell
313
-105
-25% -$4K ﹤0.01% 623
2022
Q2 		$19K Buy
418
+18
+5% +$934 ﹤0.01% 552
2022
Q1 		$30K Buy
400
+99
+33% +$8.66K ﹤0.01% 529
2021
Q4 		$45K Buy
+301
New +$46.1K ﹤0.01% 499

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Washington Trust Advisors's TXG Position: Q1 2023 in Review

Washington Trust Advisors sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 83 shares — an estimated $3.02K sold.

Washington Trust Advisors first reported a position in TXG in Q4 2021 and held it in 5 quarters. The position peaked at $45K in Q4 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • Washington Trust Advisors reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
  • Washington Trust Advisors sold 83 10x Genomics shares in Q1 2023, an estimated $3.02K.
  • Washington Trust Advisors first reported a position in 10x Genomics in Q4 2021 and held it in 5 quarters.
  • Washington Trust Advisors's 10x Genomics position peaked at $45K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Washington Trust Advisors's 13F filing for Q1 2023, filed 4 May 2023.